A month has gone by since the last earnings report for Idexx Laboratories (IDXX). Shares have lost about 0.4% in that time frame, underperforming the S&P 500. But investors have to be wondering, will ...
IDEXX Laboratories, Inc.’s IDXX strong momentum in its CAG (Companion Animal Group) Diagnostics business places it well for growth in the upcoming quarters. It is also building its global commercial ...
Stifel analyst Jonathan D. Block reiterated a Hold rating on IDEXX Laboratories, Inc. (NASDAQ:IDXX), lowering the price target to $500 from $525. IDEXX is capturing market share across multiple ...
Westbrook, Maine-based IDEXX Laboratories, Inc. (IDXX) focuses on enhancing the health and well-being of pets, people, and livestock. It develops and distributes products and services for the ...
Idexx Labs' fourth-quarter results easily surpassed analysts' expectations. However, its even stronger guidance for 2025 may have stolen the show. Set to launch its newest diagnostic instrument in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results